Literature DB >> 20628741

Clinical outcomes of patients with papillary thyroid carcinoma after the detection of distant recurrence.

Yasuhiro Ito1, Takuya Higashiyama, Yuuki Takamura, Kaoru Kobayashi, Akihiro Miya, Akira Miyauchi.   

Abstract

PURPOSE: Papillary thyroid carcinoma generally has an excellent prognosis but can have recurrence to the distant organs that is often life-threatening. To date, prognosis and prognostic factors of papillary carcinoma have been intensively investigated, but our knowledge regarding prognosis after the detection of distant recurrence remains inadequate.
METHODS: We investigated the prognosis and prognostic factors of papillary carcinoma after distant recurrence was detected during follow-up in a series of 105 patients who underwent locally curative surgery between 1987 and 2004.
RESULTS: To date, 30 patients (29%) have died of carcinoma, and the 5-year and 10-year cause-specific survival (CSS) rates after the detection of distant recurrence were 71 and 50%, respectively. Patients aged 55 years or older at recurrence or with massive extrathyroid extension of primary lesions demonstrated a significantly worse CSS. On multivariate analysis, these two parameters were recognized as independent prognostic factors. Gender, tumor size, and lymph node metastasis did not affect patient prognosis. Uptake of radioactive iodine (RAI) to distant metastasis was not significantly linked to CSS, but none of the patients younger than aged 55 years showing RAI uptake died of carcinoma. Appearance of distant recurrence to organs other than lung also predicted a dire prognosis.
CONCLUSIONS: Age at recurrence and extrathyroid extension of primary lesions were significantly related to patient prognosis after the detection of distant recurrence. RAI therapy is effective, especially for younger patients, if metastatic lesions show RAI uptake.

Entities:  

Mesh:

Year:  2010        PMID: 20628741     DOI: 10.1007/s00268-010-0712-0

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  21 in total

1.  Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.

Authors:  M Haq; C Harmer
Journal:  Clin Endocrinol (Oxf)       Date:  2005-07       Impact factor: 3.478

2.  Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.

Authors:  C Durante; N Haddy; E Baudin; S Leboulleux; D Hartl; J P Travagli; B Caillou; M Ricard; J D Lumbroso; F De Vathaire; M Schlumberger
Journal:  J Clin Endocrinol Metab       Date:  2006-05-09       Impact factor: 5.958

3.  Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients.

Authors:  M E Dottorini; A Vignati; L Mazzucchelli; G Lomuscio; L Colombo
Journal:  J Nucl Med       Date:  1997-05       Impact factor: 10.057

4.  Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population.

Authors:  Shinya Uchino; Shiro Noguchi; Hitoshi Kawamoto; Hiroyuki Yamashita; Shin Watanabe; Hiroto Yamashita; Shigeru Shuto
Journal:  World J Surg       Date:  2002-04-30       Impact factor: 3.352

5.  Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control.

Authors:  Iwao Sugitani; Yoshihide Fujimoto; Noriko Yamamoto
Journal:  Surgery       Date:  2007-12-03       Impact factor: 3.982

6.  Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma.

Authors:  M Schlumberger; M Tubiana; F De Vathaire; C Hill; P Gardet; J P Travagli; P Fragu; J Lumbroso; B Caillou; C Parmentier
Journal:  J Clin Endocrinol Metab       Date:  1986-10       Impact factor: 5.958

7.  Biological behavior and prognosis of familial papillary thyroid carcinoma.

Authors:  Yasuhiro Ito; Kennichi Kakudo; Mitsuyoshi Hirokawa; Mitsuhiro Fukushima; Tomonori Yabuta; Chisato Tomoda; Hiroyuki Inoue; Minoru Kihara; Takuya Higashiyama; Takashi Uruno; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Akira Miyauchi
Journal:  Surgery       Date:  2008-09-21       Impact factor: 3.982

8.  Expression of COX-2 is increased with age in papillary thyroid cancer.

Authors:  P Siironen; A Ristimäki; S Nordling; J Louhimo; R Haapiainen; C Haglund
Journal:  Histopathology       Date:  2004-05       Impact factor: 5.087

9.  Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine.

Authors:  F Pacini; F Cetani; P Miccoli; F Mancusi; C Ceccarelli; F Lippi; E Martino; A Pinchera
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

Review 10.  Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment.

Authors:  R F Grossman; S H Tu; Q Y Duh; A E Siperstein; F Novosolov; O H Clark
Journal:  Arch Surg       Date:  1995-08
View more
  12 in total

1.  Prognosis of patients with papillary thyroid carcinoma showing postoperative recurrence to the central neck.

Authors:  Yasuhiro Ito; Takuya Higashiyama; Yuuki Takamura; Kaoru Kobayashi; Akihiro Miya; Akira Miyauchi
Journal:  World J Surg       Date:  2011-04       Impact factor: 3.352

2.  Long-term results of surgery for papillary thyroid carcinoma with local recurrence.

Authors:  Hiroki Uchida; Tsuneo Imai; Toyone Kikumori; Hironori Hayashi; Shigenori Sato; Sumiyo Noda; Ai Idota; Tetsuya Kiuchi
Journal:  Surg Today       Date:  2012-10-10       Impact factor: 2.549

3.  Using diffusion-weighted MRI to predict aggressive histological features in papillary thyroid carcinoma: a novel tool for pre-operative risk stratification in thyroid cancer.

Authors:  Yonggang Lu; Andre L Moreira; Vaios Hatzoglou; Hilda E Stambuk; Mithat Gonen; Yousef Mazaheri; Joseph O Deasy; Ashok R Shaha; R Michael Tuttle; Amita Shukla-Dave
Journal:  Thyroid       Date:  2015-04-21       Impact factor: 6.568

4.  Long-Term Follow-Up of the Therapeutic Outcomes for Papillary Thyroid Carcinoma With Distant Metastasis.

Authors:  Jen-Der Lin; Chuen Hsueh; Tzu-Chieh Chao
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

5.  Risk Factors for Recurrence in Filipinos with Well-Differentiated Thyroid Cancer.

Authors:  Tom Edward Ngo Lo; Abigail Uy Canto; Patricia Deanna D Maningat
Journal:  Endocrinol Metab (Seoul)       Date:  2015-10-20

6.  Combined analysis of circulating epithelial cells and serum thyroglobulin for distinguishing disease status of the patients with papillary thyroid carcinoma.

Authors:  Hung-Chih Lin; Miaw-Jene Liou; Hsung-Ling Hsu; Jason Chia-Hsun Hsieh; Yi-An Chen; Ching-Ping Tseng; Jen Der Lin
Journal:  Oncotarget       Date:  2016-03-29

7.  IGFBP7 inhibits cell proliferation by suppressing AKT activity and cell cycle progression in thyroid carcinoma.

Authors:  Le Zhang; Rong Lian; Jingjing Zhao; Xianming Feng; Runyi Ye; Lingxiao Pan; Jueheng Wu; Mengfeng Li; Yongbo Huan; Junchao Cai
Journal:  Cell Biosci       Date:  2019-06-06       Impact factor: 7.133

8.  The Evaluation of Microcarcinoma in Differentiated Thyroid Cancers According to Old and New TNM Classification.

Authors:  Zekiye Hasbek; Bülent Turgut; Taner Erselcan; Ayhan Koyuncu; Mehmet Fatih Börksüz; Nergiz Hacer Turgut; Fadime Yumuk
Journal:  Mol Imaging Radionucl Ther       Date:  2011-12-01

9.  Overall Survival of Papillary Thyroid Carcinoma Patients: A Single-Institution Long-Term Follow-Up of 5897 Patients.

Authors:  Yasuhiro Ito; Akira Miyauchi; Minoru Kihara; Mitsuhiro Fukushima; Takuya Higashiyama; Akihiro Miya
Journal:  World J Surg       Date:  2018-03       Impact factor: 3.352

10.  Ki-67 and CK-19 are predictors of locoregional recurrence in papillary thyroid carcinoma.

Authors:  Aline de Oliveira Ribeiro Viana; João Gonçalves Filho; Ana Lúcia Noronha Francisco; Clóvis Antônio Lopes Pinto; Luiz Paulo Kowalski
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-06       Impact factor: 2.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.